BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 22627630)

  • 1. Overexpression of Pim-1 during progression of prostatic adenocarcinoma.
    Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L
    J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMP3 overexpression occurs in various important cancer types and is linked to aggressive tumor features: A tissue microarray study on 8,877 human cancers and normal tissues.
    Burdelski C; Jakani-Karimi N; Jacobsen F; Möller-Koop C; Minner S; Simon R; Sauter G; Steurer S; Clauditz TS; Wilczak W
    Oncol Rep; 2018 Jan; 39(1):3-12. PubMed ID: 29115542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis.
    Harrison S; Lennon R; Holly J; Higgins JPT; Gardner M; Perks C; Gaunt T; Tan V; Borwick C; Emmet P; Jeffreys M; Northstone K; Rinaldi S; Thomas S; Turner SD; Pease A; Vilenchick V; Martin RM; Lewis SJ
    Cancer Causes Control; 2017 Jun; 28(6):497-528. PubMed ID: 28361446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma.
    Lin L; Zhang J; Wang Y; Ju W; Ma Y; Li L; Chen L
    Oncol Lett; 2013 Sep; 6(3):740-744. PubMed ID: 24137402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-binding protein-2 and -3 expression in benign human prostate epithelium, prostate intraepithelial neoplasia, and adenocarcinoma of the prostate.
    Tennant MK; Thrasher JB; Twomey PA; Birnbaum RS; Plymate SR
    J Clin Endocrinol Metab; 1996 Jan; 81(1):411-20. PubMed ID: 8550786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of p21 and p27 immunoexpression in benign glands, prostatic intraepithelial neoplasia and prostate adenocarcinoma.
    Doganavsargil B; Simsir A; Boyacioglu H; Cal C; Hekimgil M
    BJU Int; 2006 Mar; 97(3):644-8. PubMed ID: 16469041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of IMP3 expression in prostate adenocarcinomas.
    Tosun Yildirim H; Sentürk N
    Turk Patoloji Derg; 2012; 28(2):128-33. PubMed ID: 22627630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in biomarker expression in the development of prostatic adenocarcinoma.
    Myers RB; Grizzle WE
    Biotech Histochem; 1997 Mar; 72(2):86-95. PubMed ID: 9152521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate pathology: histologic and molecular perspectives.
    Putzi MJ; De Marzo AM
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):407-21. PubMed ID: 11525288
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.